TAKEDA PHARMACEUTICAL COMPANY LIMITED

Consensus Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Delayed Japan Exchange Other stock markets 20:51:25 2025-07-14 EDT			5-day change	1st Jan Change
4,453.00 ^JPY	+2.11%		+1.34%	+6.48%

07-14	Sector Update: Health Care Stocks Decline Premarket Monday	MT
07-14	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Fresh Tariff Warnings	MT

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

23fa9cdcb2.iYeGhd1UiROFQJC9n73la9TyZ80MExssN4rgKhTqZZA.uf3oto0BvCrkN9zq--mMXOGfNeA9d1daeNmIX0O9IcSk9_fsj2TfZO0n1Q~39a2e7d503aec7ab94f0ec64ac16a8cf

Analysts' recommendations: Takeda Pharmaceutical Company Limited

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	05-09	MT
Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	05-06	MT
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	24-08-12	MT
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	24-07-31	MT
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	24-02-13	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	23-10-03	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	23-09-22	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	23-05-31	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	23-05-16	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	23-04-04	MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	23-03-16	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	23-03-06	MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	22-08-01	MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	22-07-19	MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	21-10-07	MT
BAYER : Germany's Merck hires JP Morgan to sell consumer health	17-09-08	RE

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	TAKEDA PHARMACEUTICAL COMPANY LIMITED					+12.99%
	ELI LILLY AND COMPANY					+20.08%
	JOHNSON & JOHNSON					+7.8%
	ABBVIE INC.					+8.66%
	NOVO NORDISK A/S					+46.89%
	ROCHE HOLDING AG					+17.36%
	NOVARTIS AG		-			+0.37%
	ASTRAZENECA PLC					+30.73%
	MERCK & CO., INC.					+22.11%
	AMGEN INC.					+6.19%
	Average					+17.32%
	Weighted average by Cap.					+18.17%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

16

Last Close Price

4,361.00JPY

Average target price

4,946.56JPY

Spread / Average Target

+13.43%

High Price Target

5,800.00JPY

Spread / Highest target

+33.00%

Low Price Target

4,500.00JPY

Spread / Lowest Target

+3.19%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
TD Cowen
BofA Securities
Cowen
Morgan Stanley

Ratings

Trading Rating

Investor Rating

ESG MSCI

A

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Equities
4502 Stock
Consensus Takeda Pharmaceutical Company Limited

As early as today, start finding the best investment opportunities!